Happiness is the new brand currency: 8 in 10 Asia Pacific consumers rely on brands for unique, transformative experiences

— Younger generations in Asia Pacific – Millennials (89%) and Gen Z (86%) – are driving the shift towards experiential brand engagement in the transformation economy — 60% of respondents in Asia Pacific prioritise rewards that strengthen ties with family and friends over self-fulfilment — Brands can become powerful drivers of customer happiness by providing […]

TotalEnergies ENEOS solarizes Lee Huat Yap Kee’s logistics facilities in Singapore

TotalEnergies ENEOS has successfully commissioned two solar rooftop photovoltaic (PV) systems for Lee Huat Yap Kee Pte Ltd (LHYK), a leading marine logistics specialist in Singapore. The newly installed systems boast a combined capacity of 1.2 megawatt-peak (MWp) powering LHYK's facilities in Singapore with renewable energy, thus contributing to their sustainability efforts. This initiative underscores

Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment<BR />

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced that it has been selected for the highest rating of "Supplier Engagement Leader" in the Supplier Engagement Rating by the global environmental non-profit organization CDP.(1) The Supplier Engagement Assessment evaluates how effectively companies are working with suppliers to address climate change issues. In its responses

Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)

— STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2] — STOBOCLO and OSENVELT, among the first wave of biosimilars referencing PROLIA and XGEVA respectively, are commercially available in the U.S. — Celltrion further expands its portfolio, delivering cost-effective and high-quality biologic medicines to wider

SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announcedtoday that the China National Medical Products Administration (NMPA) has cleared the Investigational New Drug (IND) application for SCG101V, marking the first-ever investigational cell therapy to enter regulatory approved Phase 1/2 clinical trial for

Fluence Chosen for 300 MW / 600 MWh Wellington Battery Energy Storage System for AMPYR Australia

(NASDAQ:FLNC), The project will include the full suite of Fluence's innovative storage products, including Gridstack(TM), a 20-year service contract, Mosaic bidding software, and Nispera asset performance management software SYDNEY, July 08, 2025 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a global market leader delivering intelligent energy storage, services, and asset optimization software, today

SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announcedtoday that the China National Medical Products Administration (NMPA) has cleared the Investigational New Drug (IND) application for SCG101V, marking the first-ever investigational cell therapy to enter regulatory approved Phase 1/2 clinical trial for

Tam Jai International Crowned Grand Winner with 14 Awards at Employee Experience Awards 2025

Tam Jai International Co. Limited (“TJI” or the “Company”, together with its subsidiaries, the “Group”; HKEX stock code: 2217), one of the leading and renowned restaurant groups in Hong Kong, has been named theGrand Winner at the Employee Experience Awards 2025, Hong Kong (the “Awards”), securing 14 recognitions for its outstanding achievements. Mr Derek Wu,

Black Hawk Acquisition Corporation Amends Its Definitive Proxy Statement

(NasdaqGM:BKHAU), DANVILLE, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the “Company”) announced today that it filed a supplement to its definitive proxy statement, originally filed with the Securities and Exchange Commission on June 10, 2025, to amend the language of the Trust Amendment Proposal. Originally, the Trust Amendment Proposal

Advantech Unveils Next-Generation Edge AI Compute Solutions Powered by Qualcomm Snapdragon X Elite

Advantech is proud to introduce its latest suite of high-performance edge AI compute solutions powered by the Snapdragon® X Elite platform – theAOM-6731,AIMB-293, andSOM-6820. Built on this groundbreaking platform, these innovative products are engineered to meet the demanding requirements of modern industrial applications by delivering exceptional processing power, integrated AI acceleration with up to 45

Scroll to Top